Austin Private Wealth’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$429K Sell
4,461
-92
-2% -$8.94K 0.03% 194
2025
Q3
$434K Sell
4,553
-35
-0.8% -$3.22K 0.03% 195
2025
Q2
$400K Buy
4,588
+206
+5% +$17.5K 0.03% 198
2025
Q1
$394K Buy
4,382
+506
+13% +$45.3K 0.04% 187
2024
Q4
$310K Buy
3,876
+759
+24% +$65.7K 0.03% 201
2024
Q3
$281K Buy
3,117
+14
+0.5% +$1.18K 0.03% 209
2024
Q2
$244K Buy
3,103
+315
+11% +$25.8K 0.03% 203
2024
Q1
$237K Buy
2,788
+221
+9% +$18.9K 0.03% 203
2023
Q4
$211K Buy
+2,567
New +$196K 0.03% 192
2022
Q2
Sell
-1,876
Closed -$208K 160
2022
Q1
$208K Sell
1,876
-643
-26% -$67.9K 0.04% 128
2021
Q4
$261K Buy
2,519
+120
+5% +$13.9K 0.05% 124
2021
Q3
$301K Buy
2,399
+176
+8% +$22.8K 0.06% 101
2021
Q2
$276K Buy
2,223
+211
+10% +$26.5K 0.06% 105
2021
Q1
$238K Sell
2,012
-15
-0.7% -$1.76K 0.06% 103
2020
Q4
$237K Buy
+2,027
New +$223K 0.07% 100

Other funds holding MDT

Austin Private Wealth's MDT Position: Q4 2025 in Review

Austin Private Wealth reduced its Medtronic (MDT) stake by 2% in Q4 2025, selling an estimated $8.94K and leaving 4,461 shares worth $429K. The position accounts for 0.03% of the portfolio, ranked #194.

Austin Private Wealth first reported a position in MDT in Q4 2020 and has held it in 15 quarters since. The position peaked at $434K in Q3 2025. 2,303 funds tracked by Wall St. Rank hold MDT as of Q4 2025.

  • Austin Private Wealth held 4,461 shares of Medtronic worth $429K as of Q4 2025.
  • Austin Private Wealth sold 92 Medtronic shares in Q4 2025, an estimated $8.94K.
  • Medtronic made up 0.03% of Austin Private Wealth's portfolio in Q4 2025, its #194 holding.
  • Austin Private Wealth first reported a position in Medtronic in Q4 2020 and has held it in 15 quarters since.
  • Austin Private Wealth's Medtronic position peaked at $434K in Q3 2025.
  • 2,303 funds tracked by Wall St. Rank held Medtronic as of Q4 2025.

Based on Austin Private Wealth's 13F filing for Q4 2025, filed 20 Jan 2026.